Aide is a health technology company with a mission to make prescribed care as effective as possible. Our focus is on the unsustainable trajectory of healthcare utilisation caused by long-term conditions. This represents a challenge that costs the NHS £50bn and the US health system $1tr each year. Today, 70% of all primary and acute care spending is on long-term conditions.
Aide uses natural language to help improve self-care and clinical decision-making. Specifically, Aide is designed to address the rising human and economic cost of comorbidity: individuals with two or more long term conditions which presents more than 50% of the time. Aide is live in NHS England, supporting those with Asthma and Type 2 Diabetes.
Location: United Kingdom, England, London
Member count: 1-10
Total raised: $1.210929M
Founded date: 2021
Investors 1
| Date | Name | Website |
| 11.11.2022 | Fuel Ventu... | fuel.ventu... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 25.11.2022 | Pre-Seed | $1.210929M | - | finsmes.co... |
Mentions in press and media 3
| Date | Title | Description | Category | Author | Source |
| 25.11.2022 | Aide Healt... | Aide Health, a London, UK-base... | UK | - | finsmes.co... |
| 15.11.2022 | Hambro Per... | London-based digital health ap... | - | Callum Cyr... | tech.eu/20... |
| 15.11.2022 | Aide Healt... | Remote health platform Aide He... | - | - | uktech.new... |